# What ERR activation changed in a mouse heart failure model

- Article ID: research-349
- Product: SLU-PP-332 (slu-pp-332-707)
- Canonical page: https://heritagebiolabs.com/research-library/articles/349-what-err-activation-changed-in-a-mouse-heart-failure-model
- Product collection: https://heritagebiolabs.com/research-library/products/slu-pp-332
- Product page: https://heritagebiolabs.com/product/slu-pp-332-707
- Reading focus: Mechanisms & biology (Reading focus is a navigational tag, not an evidence grade.)
- Source years: 2023

> Educational article about published research. For research use only; not medical advice. Literature does not establish the identity, purity or activity of a purchased lot, and studies of individual components do not validate a blend.

Short chains of amino acids linked by peptide bonds are peptides. Some molecules can activate signaling proteins without being made of amino-acid chains. SLU-PP-332 is a nonpeptide small molecule designed to activate estrogen-related receptors. An older animal experiment asked whether it and a separate compound, SLU-PP-915, changed heart function in mice subjected to an increased pressure load. [1]

When a heart has to pump against higher pressure, the cells can change how they use fuel. The investigators used a mouse model designed to create that stress. They assessed the fraction of blood pumped out of a ventricle with each contraction, a measure called ejection fraction. They also examined scarring and changes in the chemical reactions involved in using fats and producing energy. [1]

The study reported higher ejection fractions and less fibrosis in treated mice under the experimental conditions. The authors found changes in measures of fatty acid use and in the activity of genes involved in mitochondrial function. Their genetic experiments suggested that ERR gamma made an important contribution to the measured response. The findings came from controlled experiments with each of the two small molecules and additional work on the receptor pathway. [1]

The model represents a particular cause of strain on the mouse heart. It supplies a way to study the connection between fuel use and organ function. It does not establish the effect of the compound in people with heart failure, a condition that can arise for several reasons and can have a different course. The findings describe cardiac measurements in the tested animals and a proposed mechanism for those observations. [1]

## Sources

1. Weiyi Xu et al. Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function. Circulation (publication 2023-11-14). <https://pubmed.ncbi.nlm.nih.gov/37961903/>

## Provenance

Article titles, body paragraphs and numbered citations extracted without rewriting from owner-supplied Word volumes. Product mappings use exact catalog labels; reading-focus tags and excerpts are navigational metadata. No independent peer-review or comprehensive source verification is claimed. Source volume: Peptide Research Articles 070 - SLU-PP-332.docx; article 349; content SHA-256 1c5a327b7cc3c8761638f9713bfcd36a4e8bb3272f2ef42280cf23776b91e3ae.
